{"nct_id":"NCT00389675","title":"DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension","status":"TERMINATED","status_verified_date":"2014-01","start_date":"2007-05","start_date_type":null,"primary_completion_date":"2010-02","primary_completion_date_type":"ACTUAL","completion_date":"2010-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}